Company: PMVP
Filing Date: 2025-01-28
Form Type: S-8
Source: 0001193125-25-014448
Chunk: 1

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-01-28
Form: S-8
Chunk 1
---
ant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

REGISTRATION OF ADDITIONAL SHARES PURSUANT TO GENERAL INSTRUCTION E This Registration Statement is being filed with the Securities and Exchange Commission (the “Commission”) for the purpose of registering additional securities of the same class as other securities for which a registration statement of PMV Pharmaceuticals, Inc. (the “Registrant”) on Form S-8relating to the same employee benefit plans is effective. The number of the Registrant’s common stock available for grant and issuance under the 2020 Equity Incentive Plan (“2020 Plan”) is subject to annual increase on the first day of each fiscal year beginning with fiscal year 2021, in an amount equal to the least of (i) 4,406,374 shares, (ii) five percent (5%) of the outstanding shares of the Registrant’s common stock on the last day of the immediately preceding fiscal year or (iii) such number of shares determined by the 2020 Plan administrator. On January 1, 2025, the number of shares of the Registrant’s common stock available for grant and issuance under the 2020 Plan increased by 2,596,638 shares. This Registration Statement registers such additional shares of the Registrant’s common stock. The Registrant previously registered shares of common stock for issuance under the 2020 Plan and the 2020 Employee Stock Purchase Plan (“2020 ESPP”) pursuant to (i) a registration statement on Form S-8(File No. 333-249094)filed with the Commission on September 28, 2020, (ii) a registration statement on Form S-8(File No. 333-256346)filed with the Commission on May 21, 2021, (iii) a registration statement on Form S-8(File No. 333-262308)filed with the Commission on January 24, 2022, (iv) a registration statement on Form S-8(File No. 333-269394)filed with the Commission on January 25, 2023 and (v) a registration statement on Form S-8(File No. 333-276667)filed with the Commission on January 24, 2024 ((i), (ii), (iii), (iv) and (v), collectively, the